在引入含蛋白酶抑制剂的联合抗逆转录病毒疗法之前克罗地亚艾滋病患者的生存率。
Survival of AIDS patients in Croatia prior to the introduction of combined antiretroviral therapy with protease inhibitors.
作者信息
Begovac J, Kniewald T, Ugarković N, Lisić M, Sonicki Z, Jazbec A
机构信息
University Hospital for Infectious Diseases Dr Fran Mihaljević, Zagreb, Croatia.
出版信息
Eur J Epidemiol. 2000;16(8):741-4. doi: 10.1023/a:1026750117804.
PMID:11142502
Abstract
We report our experience on survival of adults with AIDS, treated at the University Hospital of Infectious Diseases, Zagreb, Croatia from October 1986 to December 1998. The median survival of our 116 patients was 15.8 months. Multivariate analysis showed that factors independently associated with survival were type of presenting AIDS indicator disease and CD4+ cell count.
摘要
我们报告了1986年10月至1998年12月在克罗地亚萨格勒布传染病大学医院接受治疗的成年艾滋病患者的生存情况。我们的116例患者的中位生存期为15.8个月。多变量分析表明，与生存独立相关的因素是出现的艾滋病指征性疾病类型和CD4 +细胞计数。
Zotero 插件